FCGR2B and neoplasm: The findings from this study highlight the significant role that immune markers, such as FOXP3, PD-1, and CD32B, play in the tumor microenvironment (TME) of lung adenocarcinoma, providing valuable insights into their potential as prognostic biomarkers and therapeutic targets.